Skip to main content
. 2008 Nov 25;30(8):2412–2425. doi: 10.1002/hbm.20679

Table III.

Significant paths coefficients (mean values and standard deviations) between brain regions of MS patients and controls in the entire study group and in the different centers

Connection Center Connection strength control subjects (SD) Connection strength MS patients(SD) * P
L SMC—R Cerebellum Total 0.21 (0.06) 0.19 (0.07) 0.01
Center 1 0.24 (0.06) 0.20 (0.04)
Center 2 0.24 (0.04) 0.23 (0.06)
Center 3 0.21 (0.05) 0.16 (0.05)
Center 4 0.19 (0.05) 0.14 (0.02)
Center 5 0.20 (0.06) 0.17 (0.05)
Center 6 0.21 (0.05) 0.19 (0.03)
Center 7 0.27 (0.06) 0.24 (0.10)
Center 8 0.20 (0.04) 0.17 (0.05)
L SMC—L PMd Total 0.10 (0.08) 0.15 (0.07) 0.009
Center 1 0.06 (0.03) 0.16 (0.08)
Center 2 0.07 (0.04) 0.18 (0.07)
Center 3 0.11 (0.04) 0.16 (0.09)
Center 4 0.17 (0.06) 0.12 (0.06)
Center 5 0.13 (0.09) 0.14 (0.03)
Center 6 0.10 (0.04) 0.17 (0.11)
Center 7 0.12 (0.05) 0.13 (0.07)
Center 8 0.03 (0.07) 0.13 (0.09)
L PMd—SMA Total 0.05 (0.04) 0.08 (0.05) 0.002
Center 1 0.01 (0.03) 0.07 (0.03)
Center 2 0.05 (0.05) 0.07 (0.04)
Center 3 0.04 (0.01) 0.08 (0.07)
Center 4 0.07 (0.03) 0.11 (0.08)
Center 5 0.07 (0.06) 0.14 (0.07)
Center 6 0.05 (0.04) 0.05 (0.02)
Center 7 0.04 (0.04) 0.05 (0.04)
Center 8 0.02 (0.04) 0.06 (0.05)
L SII—SMA Total 0.08 (0.04) 0.10 (0.05) 0.01
Center 1 0.05 (0.02) 0.10 (0.01)
Center 2 0.08 (0.04) 0.11 (0.04)
Center 3 0.07 (0.02) 0.09 (0.05)
Center 4 0.09 (0.05) 0.12 (0.06)
Center 5 0.11 (0.06) 0.14 (0.06)
Center 6 0.07 (0.03) 0.08 (0.02)
Center 7 0.07 (0.04) 0.09 (0.05)
Center 8 0.08 (0.03) 0.08 (0.05)
SMA—L PMd Total 0.04 (0.05) 0.08 (0.07) 0.0009
Center 1 0.01 (0.05) 0.06 (0.04)
Center 2 0.02 (0.06) 0.04 (0.04)
Center 3 0.05 (0.03) 0.10 (0.08)
Center 4 0.08 (0.02) 0.15 (0.06)
Center 5 0.09 (0.06) 0.15 (0.08)
Center 6 0.05 (0.04) 0.03 (0.04)
Center 7 0.03 (0.02) 0.06 (0.03)
Center 8 0.01 (0.04) 0.06 (0.04)
SMA—L SII Total 0.08 (0.04) 0.11 (0.05) 0.03
Center 1 0.07 (0.03) 0.09 (0.03)
Center 2 0.09 (0.04) 0.09 (0.05)
Center 3 0.09 (0.02) 0.10 (0.05)
Center 4 0.08 (0.06) 0.12 (0.08)
Center 5 0.12 (0.05) 0.13 (0.05)
Center 6 0.07 (0.02) 0.09 (0.04)
Center 7 0.07 (0.03) 0.12 (0.05)
Center 8 0.08 (0.04) 0.10 (0.04)
R SII—SMA Total 0.07 (0.04) 0.09 (0.05) 0.006
Center 1 0.05 (0.03) 0.07 (0.01)
Center 2 0.08 (0.04) 0.10 (0.04)
Center 3 0.05 (0.02) 0.08 (0.04)
Center 4 0.08 (0.04) 0.11 (0.06)
Center 5 0.10 (0.07) 0.13 (0.06)
Center 6 0.05 (0.03) 0.07 (0.02)
Center 7 0.06 (0.03) 0.09 (0.06)
Center 8 0.07 (0.04) 0.08 (0.04)
SMA—R SII Total 0.08 (0.05) 0.10 (0.05) 0.03
Center 1 0.08 (0.03) 0.09 (0.02)
Center 2 0.08 (0.04) 0.10 (0.06)
Center 3 0.07 (0.02) 0.09 (0.04)
Center 4 0.09 (0.06) 0.13 (0.05)
Center 5 0.11 (0.06) 0.12 (0.05)
Center 6 0.06 (0.05) 0.08 (0.03)
Center 7 0.07 (0.03) 0.11 (0.05)
Center 8 0.08 (0.04) 0.10 (0.04)
L SII—R SII Total 0.07 (0.04) 0.09 (0.04) 0.03
Center 1 0.06 (0.03) 0.08 (0.02)
Center 2 0.07 (0.03) 0.08 (0.05)
Center 3 0.06 (0.02) 0.09 (0.05)
Center 4 0.08 (0.05) 0.10 (0.05)
Center 5 0.09 (0.05) 0.09 (0.04)
Center 6 0.05 (0.03) 0.07 (0.02)
Center 7 0.06 (0.02) 0.13 (0.05)
Center 8 0.06 (0.02) 0.07 (0.04)
R SMC—SMA Total 0.07 (0.04) 0.09 (0.05) 0.03
Center 1 0.05 (0.02) 0.08 (0.03)
Center 2 0.09 (0.06) 0.10 (0.04)
Center 3 0.06 (0.02) 0.07 (0.06)
Center 4 0.08 (0.03) 0.13 (0.07)
Center 5 0.10 (0.05) 0.13 (0.06)
Center 6 0.06 (0.04) 0.07 (0.04)
Center 7 0.05 (0.04) 0.08 (0.05)
Center 8 0.08 (0.04) 0.09 (0.05)

Only connections significantly different between controls and MS patients have been reported.

L, left; R, right; SMC, primary sensorimotor cortex; PMd, dorsal prefrontal cortex; SMA, supplementary motor area; SII, secondary sensorimotor cortex.

*

ANOVA, adjusted for center effect and age and adjusted for multiple comparisons.

HHS Vulnerability Disclosure